CAS 1009119-65-6
:Daclatasvir-Dihydrochlorid
- Bms 790052-05
- Carbamic acid, N,N′-[[1,1′-biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C′-dimethyl ester, hydrochloride (1:2)
- Daclatasvir dihydrochloride
- Daclatasvir.2HCL
- Daklinza
- N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride
Daclatasvir Dihydrochloride
CAS:Daclatasvir DihydrochlorideFormel:C40H52Cl2N8O6Reinheit:>98%Molekulargewicht:811.8Daclatasvir dihydrochloride
CAS:Daclatasvir dihydrochlorideFormel:C40H52Cl2N8O6Reinheit:≥98%Molekulargewicht:811.8Daclatasvir dihydrochloride
CAS:Daclatasvir dihydrochloride is an oral antiviral that treats chronic hepatitis C by inhibiting HCV's NS5A; rare liver enzyme elevation, seldom causes jaundice.Formel:C40H52Cl2N8O6Reinheit:99.67%Farbe und Form:SolidMolekulargewicht:811.8Ref: TM-T1786
5mg39,00€10mg48,00€1mL*10mM (DMSO)49,00€25mg57,00€50mg67,00€100mg77,00€500mg161,00€1g230,00€Daclatasvir 2HCl
CAS:Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate dihydrochlorideFormel:C40H52Cl2N8O6Reinheit:98+%Molekulargewicht:811.8Daclatasvir Dihydrochloride
CAS:Kontrolliertes ProduktApplications Daclatasvir Dihydrochloride is an anti-hepatitis C drug.
References Song, B., et. al.: Zhongguo Xinyao Zazhi, 22, 2679 (2013); Gao, M., et al.: Nature, 465(7294), 96 (2010); Bell, T. W., Chem. Med. Chem., 5(10), 1663 (2010);Formel:C40H50N8O6·2HClFarbe und Form:NeatMolekulargewicht:811.8Daclatasvir dihydrochloride
CAS:Daclatasvir is a direct-acting antiviral agent that inhibits the activity of the NS5A protein, which is a nonstructural protein required for viral replication. It has been shown to be active against hepatitis C virus (HCV) genotype 1b and genotype 2a and also has synergistic activity with other antiviral agents. Daclatasvir has been shown to have significant cytotoxicity against cells in culture. The drug may interact with some drugs and can affect the pharmacokinetics of other drugs. Daclatasvir is metabolized by cytochrome P450 enzymes, which could lead to drug-drug interactions. Daclatasvir is a substrate for polymerase chain reaction amplification methods, such as real-time PCR, limiting its use as a diagnostic tool.
Formel:C40H50N8O6·2HClReinheit:Min. 95%Farbe und Form:White PowderMolekulargewicht:811.8 g/molCarbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester, hydrochloride (1:2)
CAS:Formel:C40H51ClN8O6Reinheit:%Farbe und Form:SolidMolekulargewicht:775.3359Ref: IN-DA00036J
Ausgelaufenes produkt







